BridgeBio Pharma, Inc.BBIONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR+2.6%
5Y CAGR-49.4%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+2.6%/yr
Annual compound
5Y CAGR
-49.4%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 34.35 | +23.8% |
| 2024 | 27.74 | -96.7% |
| 2023 | 853.04 | +2581.0% |
| 2022 | 31.82 | -40.7% |
| 2021 | 53.65 | -94.8% |
| 2020 | 1034.11 | +1129.4% |
| 2019 | 84.12 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |